Management of Irregular Menstrual Cycle with Mild Hyperandrogenism and Controlled Hyperprolactinemia

Diagnostic Priorities

Measure androstenedione and DHEAS levels to rule out adrenal or ovarian tumors, particularly since testosterone is elevated, with androstenedione >10.0 nmol/L or age-adjusted DHEAS elevation (>3800 ng/ml for ages 20-29, >2700 ng/ml for ages 30-39) requiring imaging 1, 2
Obtain LH and FSH levels (average of three measurements 20 minutes apart) to assess for PCOS pattern (LH/FSH ratio >2) versus other causes 1, 2, 3
Check mid-luteal progesterone when cycles resume to confirm ovulation status, as levels <6 nmol/L indicate anovulation 1, 2
Perform pelvic ultrasound (transvaginal preferred) to evaluate for polycystic ovaries (>10 peripheral cysts, 2-8 mm diameter) or masses 1, 2, 4
Screen for metabolic complications with fasting glucose, 2-hour oral glucose tolerance test, and fasting lipid panel, as insulin resistance commonly accompanies hyperandrogenism 1, 3

The American College of Obstetricians and Gynecologists recommends initiating combined oral contraceptives (COCs) as first-line therapy to regulate menstrual cycles and reduce hyperandrogenism 3
Prefer 17β-estradiol-based COCs (such as 17βE + nomegestrol acetate or 17βE + dienogest) over ethinylestradiol formulations when available, as they have more favorable metabolic profiles 5
Add metformin 1000 mg daily if insulin resistance is confirmed on testing or if BMI is elevated, with the combination of cabergoline plus metformin showing superior outcomes for cycle regularity and androgenic profile improvement compared to metformin alone in PCOS patients with hyperprolactinemia 3

Implement lifestyle modifications including diet and exercise for weight management, as weight gain is a trigger for PCOS development and worsens hyperandrogenism 1, 6, 3

Non-classical congenital adrenal hyperplasia causes modest testosterone elevation and requires DHEAS measurement 1, 2, 3
Ovarian or adrenal tumors must be excluded with androstenedione measurement and imaging if levels are significantly elevated 1, 2, 3
Hypothalamic amenorrhea presents with low LH levels and amenorrhea but typically without hyperandrogenism 6
Thyroid dysfunction should be excluded with TSH measurement, as it commonly causes menstrual irregularity 2, 4, 3

Reassess menstrual cycles monthly to confirm restoration of regular 23-35 day intervals 2, 4
Recheck testosterone and prolactin levels at 3 months after initiating COCs to confirm biochemical improvement 3
Monitor for metabolic complications annually with glucose and lipid screening, as hyperandrogenism increases cardiovascular risk 3
Address psychological impact of hirsutism and menstrual irregularity as part of comprehensive care 3